MedPath

Comparison of the effect of intravenous selenium and magnesium sulfate on the clinical outcomes of patients with severe traumatic brain injury in the intensive care unit.

Phase 1
Conditions
Severe traumatic brain injury.
Traumatic cerebral edema
S06.1
Registration Number
IRCT20240605062022N1
Lead Sponsor
Oroumia University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
110
Inclusion Criteria

Patients with blunt trauma
All patients with a level of consciousness score greater than 3 to 8 referred to Imam Khomeini Hospital in Urmia, and the written consent form to participate in the research project has been signed by the first degree relatives of the patient (father-mother-spouse-child).

Exclusion Criteria

People with end stage chronic disease
Dialysis patients
pregnant women
Active gastrointestinal bleeding
Post CPR patients
Glasgow coma score equal to 3
Pupil without reaction to bilateral light
Probability of surviving less than 24 hours
Systolic blood pressure less than 90 mmHg for more than 10 minutes
Spinal cord injury
A known case of kidney, liver and heart failure

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath